Background
Mortality data from the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium inform models used by UNAIDS to estimate the number of children (aged <15 years) living with HIV (CLHIV) and AIDS-related deaths annually. Previous IeDEA mortality estimates used data up to 2017. We updated all-cause mortality among CLHIV on ART and described trends from 2004-2020.
Methods
We included routinely-collected data from CLHIV on ART during 2004-2020 with recorded CD4 values at ART start, across 59 programs in Africa, the Asia-Pacific and Latin America and the Caribbean. We used mixed-effects Poisson regression models to estimate mortality by age, sex, CD4 at ART start, time on ART, region, and calendar period (using linear splines); with separate models for African and non-African regions, and for younger (<5) and older (≥5-<15 years) CLHIV. We allowed for distinct covariate effects by ART duration category (<1 year vs. ≥1 year). Before model fitting, for African regions, we adjusted IeDEA routine data to account for unascertained mortality among those lost to follow-up (LTFU), using data from an IeDEA tracing study of 2013-2017 (n=221) to simulate mortality among those LTFU with a Gompertz survival model.
Results
We included 43,058 CLHIV and observed 3,024 deaths over 171,209 person-years, with a crude recorded mortality rate of 1.8 (95% Confidence Interval [CI]: 1.7-1.8) deaths per 100 person-years. Mortality declined in more recent calendar years and was highest in those with lower CD4, shorter ART duration, and age <1 year (Figure). Mortality rates were similar across sexes.
Compared to 2017, mortality within the first year on ART in 2020 was similar or lower among CLHIV aged <5 years (Rate Ratio [RR] 0.79, 95% CI: 0.68–0.92 [non-African regions]; 0.78, 95% CI: 0.52–1.17 [African regions]) and among those ≥5 years (RR 0.67, 95% CI: 0.49–0.92 [non-African regions]; 1.15, 95% CI: 0.81–1.62 [African regions]). For CLHIV on ART >1 year, 2020 mortality vs. 2017 was 0.73 (95% CI: 0.51–1.04) and 1.01 (95% CI 0.61–1.66) in those aged <5 years in non-African and African regions, respectively, and 0.75 (95% CI 0.61–0.94) and 0.81 (95% CI 0.68–0.98) in those ≥5 years.
Conclusions
Since 2017, on-ART mortality among CLHIV continued to decline, particularly for older CLHIV and in non-African regions. Declines for younger CLHIV and those in African regions were smaller and less certain. Our updated IeDEA mortality estimates support UNAIDS to continue modelling global pediatric HIV.
Table or Figure
